Expert Health Tech Leader Brings Extensive Experience in Connected Care, Life Sciences, and Chronic Condition Management to Drive Global Growth

专家级健康技术领导者在关联护理、生命科学和慢性病管理方面拥有丰富的经验，以推动全球增长

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, today announced that it has secured a $100 million Series F financing. The Company’s Board of Directors also announced the appointment of Mike Alvarez as Chief Executive Officer..

Glooko，Inc.是一家连接患者、提供者、生物制药和医疗设备合作伙伴的全球综合数字健康公司，今天宣布已获得1亿美元的F系列融资。公司董事会还宣布任命迈克·阿尔瓦雷斯为首席执行官。。

The financing round, led by Georgian, with investments from Health Catalyst Capital, Canaan, and other investors and business partners, will support Glooko’s continued growth and product expansion in expert data insights, device integrations, clinical research, and chronic condition support for healthcare providers around the world.

这轮融资由格鲁吉亚牵头，由Health Catalyst Capital、迦南和其他投资者和商业合作伙伴投资，将支持Glooko在专家数据见解、设备集成、临床研究和慢性病支持方面的持续增长和产品扩展，为世界各地的医疗保健提供者提供支持。

This funding, coupled with the appointment of Alvarez as CEO, will allow Glooko to accelerate global product expansion of its cutting-edge digital healthcare platform and life sciences work, which empowers people with diabetes to better manage their condition and strengthen the engagement with and care from their healthcare team..

这笔资金，再加上任命阿尔瓦雷斯为首席执行官，将使Glooko加速其尖端数字医疗平台和生命科学工作的全球产品扩展，从而使糖尿病患者能够更好地管理自己的病情，并加强其医疗团队的参与和护理。。

“On behalf of the Board of Directors, we are delighted to welcome Mike Alvarez as the new leader of Glooko,” said Simon Chong, Co-Founder at Georgian and Chairman of the Board of Directors at Glooko. “Today, more than 537 million adults worldwide are diagnosed with diabetes, and the numbers are projected to grow every year.

乔治亚大学联合创始人、格罗奥科大学董事会主席西蒙·钟（SimonChong）表示：“我们很高兴代表董事会欢迎迈克·阿尔瓦雷斯（MikeAlvarez）担任格罗奥科大学的新领导人。“今天，全世界有超过5.37亿成年人被诊断患有糖尿病，预计这一数字每年都会增加。

The need for timely, comprehensive, and integrated support for healthcare practitioners is critical. Mike brings significant industry expertise, proven leadership, and commercial success across chronic condition management and population health, as well as experience with advanced data management technologies.

对医疗保健从业人员及时，全面和综合支持的需求至关重要。Mike在慢性病管理和人群健康方面带来了重要的行业专业知识、成熟的领导力和商业成功，以及先进数据管理技术的经验。

We believe Mike is the right leader at a key inflection point for Glooko and look forward to working with him.”.

我们相信Mike是Glooko在关键转折点的正确领导者，并期待着与他合作。”。

Alvarez brings more than two decades of leadership experience with multinational companies in medical devices and biotechnology. Most recently, Alvarez served as Chief Executive Officer at Qardio, a leader in remote patient monitoring and technology solutions for chronic disease management. Prior to Qardio, Alvarez held leadership positions at Medtronic, St.

阿尔瓦雷斯在医疗器械和生物技术领域拥有20多年的跨国公司领导经验。最近，阿尔瓦雷斯担任Qardio的首席执行官，Qardio是慢性病管理远程患者监测和技术解决方案的领导者。在卡迪奥之前，阿尔瓦雷斯曾在圣路易斯美敦力担任领导职务。

Jude Medical (acquired by Abbott), and Sanofi..

裘德医疗（被雅培收购）和赛诺菲。。

“The healthcare industry is currently navigating significant challenges related to data burden and clinical workflows, particularly for physicians working with patients to manage chronic conditions,” said Alvarez. “By unifying data from multiple devices onto one standardized platform, we can simplify decision-making and empower providers to translate vast amounts of data into meaningful insights.

阿尔瓦雷斯说：“医疗保健行业目前面临着与数据负担和临床工作流程相关的重大挑战，特别是对于与患者合作管理慢性病的医生来说。”。“通过将来自多个设备的数据统一到一个标准化平台上，我们可以简化决策，并使供应商能够将大量数据转化为有意义的见解。

This enables timely interventions and helps create new clinical care pathways that can enhance patient outcomes. I am thrilled to join Glooko at this pivotal moment in its journey. I look forward to continued commercial acceleration as we leverage real-world data to transform chronic condition management and improve enrollment and management in clinical trials through diverse and inclusive populations.”.

这可以及时干预，并有助于创建新的临床护理途径，以提高患者的预后。我很高兴能在Glooko旅程的关键时刻加入它。随着我们利用现实世界的数据来改变慢性病管理，并通过多样化和包容性的人群改善临床试验的登记和管理，我期待着持续的商业加速。”。

About Glooko

关于Glooko

Glooko improves the health outcomes of people with chronic conditions through its personalized, intelligent, connected care and life sciences platform. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials.

Glooko通过其个性化、智能化、互联护理和生命科学平台改善慢性病患者的健康状况。我们经过验证的技术通过彻底改变患者和提供者之间的联系，通过数字治疗推动患者参与和坚持，并加快临床试验的速度，从而改善生活。

More than 4.4 million people around the world with diabetes have used the Glooko platform. For more information, please visit our website..

全球超过440万糖尿病患者使用了Glooko平台。有关更多信息，请访问我们的网站。。

About Georgian

关于格鲁吉亚语

Georgian invests in high-growth B2B software companies and builds software to help those companies scale faster through our AI Lab. We seek to identify and accelerate leading growth-stage software companies in our thesis areas of Applied AI and Trust. Based in Toronto, Georgian’s team brings together investors with machine learning professionals, software entrepreneurs, and experienced operators.

格鲁吉亚投资于高增长的B2B软件公司，并通过我们的人工智能实验室构建软件，以帮助这些公司更快地扩大规模。我们寻求在我们的应用人工智能和信托领域确定并加速领先的成长期软件公司。总部位于多伦多的格鲁吉亚团队将投资者、机器学习专业人士、软件企业家和经验丰富的运营商聚集在一起。

Founded in 2008, Georgian has US$5.6B AUM as of December 31, 2023..

格鲁吉亚成立于2008年，截至2023年12月31日，其资产管理规模为56亿美元。。

Originally announced October 10th, 2024

最初于2024年10月10日宣布

TagsAbbott Canaan Georgian Glooko Glooko Inc. Health Catalyst Capital Health IT Funding Health IT Fundings Health IT Investment Medtronic Mike Alvarez Qardio Sanofi Simon Chong St. Jude Medical

TagsAbbott Canaan Georgian Glooko Glooko Inc.Health Catalyst Capital Health IT Funding Health IT Fundings Health IT投资美敦力Mike Alvarez Qardio Sanofi Simon Chong St.Jude Medical

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息